Related references
Note: Only part of the references are listed.Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
Lanfranco Pellesi et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine
Peer Tfelt-Hansen et al.
CNS DRUGS (2017)
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
Marcelo E. Bigal et al.
NEUROLOGY (2016)
Targeting CGRP: A New Era for Migraine Treatment
Stephanie Wrobel Goldberg et al.
CNS DRUGS (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache
Jeffrey L. Jackson et al.
PLOS ONE (2015)
Latin American consensus on guidelines for chronic migraine treatment
Alex Rodrigo Espinoza Giacomozzi et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2013)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Psychiatric comorbidities of episodic and chronic migraine
Dawn C. Buse et al.
JOURNAL OF NEUROLOGY (2013)
Low-Dose Topiramate Plus Sodium Divalproate for Positive Responders Intolerant to Full-Dose Monotherapy
Abouch Valenty Krymchantowski et al.
HEADACHE (2012)
Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
Dawn C. Buse et al.
HEADACHE (2012)
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
Elizabeth Loder et al.
HEADACHE (2012)
Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders
Abouch Valenty Krymchantowski et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Polytherapy for migraine prophylaxis
G. Casucci et al.
NEUROLOGICAL SCIENCES (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Polytherapy for the prophylaxis of chronic migraine: an Italian survey
D. D'Amico et al.
NEUROLOGICAL SCIENCES (2011)
Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study
A. I. Scher et al.
CEPHALALGIA (2010)
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
S. Silberstein et al.
CEPHALALGIA (2008)
Migraine-associated risks and comorbidity
H. C. Diener et al.
JOURNAL OF NEUROLOGY (2008)
Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment
Marcelo E. Bigal et al.
NEUROLOGY (2008)
Pharmacological approaches to managing migraine and associated comorbidities - Clinical considerations for monotherapy versus polytherapy
Stephen D. Silberstein et al.
HEADACHE (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity
TJ Steiner et al.
CEPHALALGIA (2003)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)